Publicacións nas que colabora con Ana Moyá Álvarez (15)

2021

  1. Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 953-961

2020

  1. Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as corroborated by the Hygia Chronotherapy Trial. Rebuttal to European Society of Hypertension officials.

    Chronobiology International, pp. 1-10

  2. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial

    European heart journal, Vol. 41, Núm. 48, pp. 4565-4576

2019

  1. Asleep (not night-time) blood pressure as prognostic marker of cardiovascular risk

    European Heart Journal

2018

  1. Asleep blood pressure: Significant prognostic marker of vascular risk and therapeutic target for prevention

    European Heart Journal, Vol. 39, Núm. 47, pp. 4159-4171

2015

  1. Monitorización ambulatoria de la presión arterial en diabetes para valoración y control de riesgo vascular

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 62, Núm. 8, pp. 400-410

2014

  1. Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy

    Nephrology Dialysis Transplantation, Vol. 29, Núm. 6, pp. 1160-1167

  2. Chronotherapeutics of conventional blood pressure-lowering medications: Simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders topical collection on antihypertensive agents: Mechanisms of drug action

    Current Hypertension Reports, Vol. 16, Núm. 2

2013

  1. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals

    Chronobiology International, Vol. 30, Núm. 3, pp. 355-410

  2. Chronotherapy improves blood pressure control and reduces vascular risk in CKD

    Nature Reviews Nephrology, Vol. 9, Núm. 6, pp. 358-368

  3. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes

    Chronobiology International, Vol. 30, Núm. 1-2, pp. 99-115

  4. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease

    Chronobiology International, Vol. 30, Núm. 1-2, pp. 145-158

  5. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes

    Chronobiology International, Vol. 30, Núm. 1-2, pp. 116-131

  6. Recomendaciones 2013 para el uso de la monitorización ambulatoria de la presión arterial para el diagnóstico de hipertensión en adultos, valoración de riesgo cardiovascular y obtención de objetivos terapéuticos (resumen). Recomendaciones conjuntas de la International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Sociedad Española de Cronobiología Aplicada, Cronoterapia y Riesgo Vascular (SECAC), Sociedad Española de Arteriosclerosis (SEA) y Romanian Society of Internal Medicine (RSIM)

    Clínica e investigación en arteriosclerosis, Vol. 25, Núm. 2, pp. 74-82

  7. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension

    Chronobiology International, Vol. 30, Núm. 1-2, pp. 192-206